文献速递血液净化与透析水电解质与酸碱

接受标准透析液持续低效透析的重症患者中的低磷血症

Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

本研究回顾性分析65例接受至少3次持续低效透析(SLED)的ICU重症肾衰竭患者,共195次SLED。低磷血症频率随SLED次数增加而升高(P=0.012)。校正混杂因素后,静脉补磷与ICU死亡率降低相关(校正HR 0.24,95%CI 0.06-0.89,P=0.033)。

要点

  • SLED使用标准透析液时低磷血症常见,且随治疗强度增加而加重。
  • 低磷血症后仅26.7%(12/45)的SLED次安排了静脉补磷。
  • 静脉补磷与ICU死亡率降低相关(校正HR 0.24,95%CI 0.06-0.89)。

核心结论

  • 低磷血症是接受标准透析液SLED的重症患者的常见并发症,且随SLED治疗强度增加而加重。
  • 在接受每日SLED的患者中,补磷与ICU死亡率降低强烈相关。

研究设计与样本

  • 回顾性队列分析,纳入65例需要肾脏替代治疗的ICU重症肾衰竭患者,共195次SLED,每次间隔24-72小时,每日监测血清磷浓度。
  • SLED采用局部枸橼酸抗凝,使用常规透析机或连续肾脏替代治疗机及标准透析液;由主治医师决定是否静脉补充五水甘油磷酸钠。
  • 采用混合效应模型分析血清磷的决定因素,采用含时变协变量的Cox比例风险回归模型分析血清磷、静脉补磷与ICU死亡率的关系。

主要发现

  • 患者平均年龄68岁(SD 10.0),平均APACHE II评分25(范围9-40);首次SLED前平均血清磷(基线)为5.6 ± 2.1 mg/dL(范围1.5-12.3)。
  • 每次SLED结束时血清磷水平随年龄、SLED时长和SLED次数增加而降低(所有P < .05)。
  • 低磷血症频率从第1次至第3次SLED后增加(P = .012)。
  • 12/45(26.7%)次并发低磷血症的SLED后安排了静脉补磷。
  • 总体ICU死亡率为23.1%(15/65);校正潜在混杂因素和当前血清磷后,静脉补磷与ICU死亡率降低相关(校正HR 0.24,95%CI 0.06-0.89,P = 0.033)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients admitted to the Intensive Care Unit (ICU), Kidney Replacement Therapy (KRT) is an important risk factor for hypophosphataemia. However, studies addressing the development of hypophosphatemia during prolonged intermittent KRT modalities are lacking. Thus, we evaluated the incidence of hypophosphatemia during Sustained Low-Efficiency Dialysis (SLED) in ICU patients; we also examined the determinants of post-SLED serum phosphate level (s-P) and the relation between s-P and phosphate supplementation and ICU mortality. METHODS: We conducted a retrospective analysis on a cohort of critically ill patients with severe renal failure and KRT need, who underwent at least three consecutive SLED sessions at 24-72 h time intervals with daily monitoring of s-P concentration. SLED with Regional Citrate Anticoagulation (RCA) was performed with either conventional dialysis machines or continuous-KRT monitors and standard dialysis solutions. When deemed necessary by the attending physician, intravenous phosphate supplementation was provided by sodium glycerophosphate pentahydrate. We used mixed-effect models to examine the determinants of s-P and Cox proportional hazards regression models with time-varying covariates to examine the adjusted relation between s-P, intravenous phosphate supplementation and ICU mortality. RESULTS: We included 65 patients [mean age 68 years (SD 10.0); mean Acute Physiology and Chronic Health Evaluation II score 25 (range 9-40)] who underwent 195 SLED sessions. The mean s-P before the start of the first SLED session (baseline s-P) was 5.6 ± 2.1 mg/dL (range 1.5-12.3). Serum phosphate levels at the end of each SLED decreased with increasing age, SLED duration and number of SLED sessions (P < .05 for all). The frequency of hypophosphatemia increased after the first through the third SLED session (P = .012). Intravenous phosphate supplementation was scheduled after 12/45 (26.7%) SLED sessions complicated by hypophosphataemia. The overall ICU mortality was 23.1% (15/65). In Cox regression models, after adjusting for potential confounders and for current s-P, intravenous phosphate supplementation was associated with a decrease in ICU mortality [adjusted hazard ratio: 0.24 (95% confidence interval: 0.06 to 0.89; P = 0.033)]. CONCLUSIONS: Hypophosphatemia is a frequent complication in critically ill patients undergoing SLED with standard dialysis solutions, that worsens with increasing SLED treatment intensity. In patients undergoing daily SLED, phosphate supplementation is strongly associated with reduced ICU mortality.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Di Mario F, Regolisti G, Maggiore U, et al. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions. Nephrol Dial Transplant. 2022. PMID: 35481705. doi:10.1093/ndt/gfac159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。